Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Quote. Delayed Nasdaq - 09/27 04:00:00 pm
408.84 USD   -4.95%
09/27INSIDER SELL : Moderna
MT
09/27Kraton, Hess rise; Apple, Moderna fall
AQ
09/27MODERNA : U.S. administers 390.7 mln doses of COVID-19 vaccines - CDC
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : FDA asks Pfizer and Moderna to expand COVID-19 vaccine pediatric studies- NYT

07/26/2021 | 01:05pm EDT

July 26 (Reuters) - U.S. regulators have asked Pfizer Inc -BioNTech and Moderna Inc to expand the size of ongoing trials testing their COVID-19 vaccines in children aged between five and 11, the New York Times reported on Monday.

The Food and Drug Administration has indicated that the current strength of the studies was inadequate to detect the rare side effects, including myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the lining around the heart, the report said. (https://nyti.ms/3xgzuWZ)

The health regulator has asked the companies to include 3,000 children in their trials, almost double the original number of study participants, the report said, citing people familiar with the matter.

FDA, Pfizer and Moderna did not immediately respond to Reuters request for comment. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)


ę Reuters 2021
All news about MODERNA, INC.
09/27INSIDER SELL : Moderna
MT
09/27Kraton, Hess rise; Apple, Moderna fall
AQ
09/27MODERNA : U.S. administers 390.7 mln doses of COVID-19 vaccines - CDC
RE
09/27MODERNA : U.S. CDC Says Delivered 471,818,715 Doses Of Covid-19 Vaccine As Of Sept 27
RE
09/27MODERNA : EMA Starts Review of Moderna's COVID-19 Booster Shot
MT
09/27MODERNA : EU reviewing data on Moderna's COVID-19 booster shot
RE
09/27MODERNA : Hy-Vee Now Offering Free Pfizer-BioNTech COVID-19 Booster Vaccines to Eligible I..
AQ
09/27GLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
09/27MODERNA : EU evaluating data on Moderna's COVID-19 vaccine booster dose
RE
09/27WALL STREET STOCK EXCHANGE : A new gift from China
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 333 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 13,8x
Yield 2021 -
Capitalization 165 B 165 B -
EV / Sales 2021 7,48x
EV / Sales 2022 6,77x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 408,84 $
Average target price 307,77 $
Spread / Average Target -24,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.291.35%165 027
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.38.49%50 128
CELLTRION, INC.-25.49%31 745
SEAGEN INC.-7.21%29 353
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.73.08%23 097